{"id":678,"date":"2019-01-07T19:11:40","date_gmt":"2019-01-07T19:11:40","guid":{"rendered":"https:\/\/retinamdoc.com\/?page_id=678"},"modified":"2023-06-12T02:59:54","modified_gmt":"2023-06-12T09:59:54","slug":"in-the-news","status":"publish","type":"page","link":"https:\/\/retinamdoc.com\/about-me\/in-the-news\/","title":{"rendered":"In The News"},"content":{"rendered":"<p><strong><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-medium wp-image-1317\" src=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/09\/Sean_Adrean-300x238.png\" alt=\"\" width=\"300\" height=\"238\" srcset=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/09\/Sean_Adrean-300x238.png 300w, https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/09\/Sean_Adrean-768x609.png 768w, https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/09\/Sean_Adrean.png 808w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/strong><\/p>\n<p><a href=\"https:\/\/investors.adverum.com\/news\/news-details\/2022\/Adverum-Biotechnologies-Announces-First-Subject-Dosed-with-Ixo-vec-in-the-Phase-2-LUNA-Trial-for-the-Treatment-of-Wet-Age-Related-Macular-Degeneration\/default.aspx\">link1\u00a0<\/a> <a href=\"https:\/\/mailchi.mp\/db446a9d047f\/ocep-reception-2022-thank-you?e=f2e69564f1\">link2\u00a0<\/a><\/p>\n<p>The Orange County Eye Project (OCEP) was started to help the underserved population in Orange County to receive retina care for blinding eye disease such as diabetic retinopathy. OCEP has expanded its services to address the underserved population&#8217;s general ophthalmology needs as well. Dr. Adrean serves on the advisory board for OCEP and was part of the planning committee to host this inaugural charitable event.<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/14\/2515906\/32452\/en\/Adverum-Biotechnologies-Announces-First-Subject-Dosed-with-Ixo-vec-in-the-Phase-2-LUNA-Trial-for-the-Treatment-of-Wet-Age-Related-Macular-Degeneration.html\">OCEP Reception 2022<\/a><\/p>\n<p>Retina Surgical Videos:<\/p>\n<p><strong><u>February 2018<\/u><\/strong>: <a href=\"http:\/\/retinalinkglobal.com\/sean-adrean-md-faao-autologous-retinal-transplant-patient-previous-macular-hole-amd\/\">RetinaLink<\/a> \u2013 <strong>EYE on the Future Surgical Video<\/strong> with <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean Adrean, M.D<\/a>.\u00a0 <em>Autologous Retinal Transplant in Patient with Previous Macular Hole &amp; AMD<\/em>.<\/p>\n<p><iframe src=\"https:\/\/www.youtube.com\/embed\/KsDYDegHgR4\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><strong><u>August 2017:<\/u><\/strong> <a href=\"http:\/\/retinalinkglobal.com\/dr-sean-adrean-describes-retinal-transplant-technique-68-year-old-patient\/\">RetinaLink<\/a> \u2013 <strong>EYE on the Future Surgical Video<\/strong> with <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean Adrean, M.D<\/a>.\u00a0 <em>Retinal Transplant Technique on 68-year patient.<\/em><\/p>\n<p><iframe src=\"https:\/\/www.youtube.com\/embed\/XYE5AvmxBRw\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><strong><u>August 2017:<\/u><\/strong>Autologous Retinal Transplant<\/p>\n<p><iframe src=\"https:\/\/www.youtube.com\/embed\/KsDYDegHgR4\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><strong>NEWS:<\/p>\n<p><\/strong><\/p>\n<p><strong>American Society of Retina Specialists &#8211;<a href=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2023\/06\/Highlights-from-Vit.pdf\" target=\"_blank\" rel=\"noopener\">Highlights from Vit-Buckle 2023<\/a><\/strong><\/p>\n<p><strong>Retina FYI &#8211; May 10, 2023 &#8212; Volume 13, Number 18<\/strong> &#8211; <strong><a href=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2023\/06\/RETINE-FYI-V13N18.pdf\" target=\"_blank\" rel=\"noopener\">RETINE FYI V13N18<\/a><\/strong><\/p>\n<p style=\"font-weight: 400;\"><a href=\"https:\/\/www.touchophthalmology.com\/macular-degeneration\/journal-articles\/an-update-on-diabetic-macular-oedema-and-neovascular-age-related-macular-degeneration-treatments-high-dose-aflibercept-potentially-a-new-standard-of-care-with-increased-dosing-intervals\/\"><strong>High-dose Aflibercept with Increased Dosing Intervals as a New Standard of Care for DMO and nAMD<\/strong><\/a><\/p>\n<p><strong><br \/>\n<a href=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/07\/RHOS-AGENDA-SUMMER-CE-2022.pdf\" target=\"_blank\" rel=\"noopener\">RIO HONDO OPTOMETRIC SOCIETY 28th ANNUAL SUMMER CE SPECTACULAR<\/a><br \/>\n<a href=\"https:\/\/retinamdoc.com\/wp-content\/uploads\/2022\/07\/RHOS-Summer-CE-2022-Flyer-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">RIO HONDO OPTOMETRIC SOCIETY&#8217;S 28TH ANNUAL Summer CE Spectacular<\/a><br \/>\n<\/strong><\/p>\n<p class=\"m_3076387519865962298ydpffd17998yiv6320113208ydp2d5a36c3yiv3171430930ydpb68cf1f1yiv7140578870ydp603684c8yiv8315174013ydpc6ce9650MsoNormal\" style=\"text-align: left;\" align=\"center\"><b>May 2019: Dr. Adrean recently appeared at OCSO Grand Rounds in Costa Mesa to present information about the <\/b><b>management of a Subretinal Infiltrate.<\/b><\/p>\n<p><strong><u>March 2018<\/u><\/strong>: <a href=\"https:\/\/www.ophthalmologyretina.com\/article\/S2468-6530(17)30238-5\/fulltext\">Ophthalmology Retina<\/a> \u2013 <strong>Recurrence Rate of choroidal Neovascularization in Newovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol<\/strong>.\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean D. Adrean, MD<\/a>, Siyang Chaili, BS, <a href=\"https:\/\/retinamdoc.com\/provider\/scott-grant-m-d\/\">Scott Grant, MD<\/a>, <a href=\"https:\/\/retinamdoc.com\/provider\/ash-pirouz-m-d\/\">Ash Pirouz, MD<\/a>.<\/p>\n<p><strong><u>November 2017<\/u><\/strong>: <a href=\"https:\/\/www.aaojournal.org\/article\/S0161-6420(17)33259-1\/abstract\">Journal of Opthalmology &#8211; American Academy of Ophthalmology<\/a> \u2013 <strong>Consistent Long-Term Therapy of Neovascular Age-Related Macular Degeneration Managed by 50 or More Anti-VEGF Injections Using a Treat-Extend-Stop Protocol.<\/strong>\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean Adrean, MD<\/a>, Siyang Chaili, BS, <a href=\"https:\/\/retinamdoc.com\/provider\/hema-ramkumar-m-d\/\">Hema Ramkumar, MD<\/a>, <a href=\"https:\/\/retinamdoc.com\/provider\/ash-pirouz-m-d\/\">Ash Pirouz, MD<\/a> and <a href=\"https:\/\/retinamdoc.com\/provider\/scott-grant-m-d\/\">Scott Grant, MD. <\/a><\/p>\n<p><strong><u>October 2017<\/u><\/strong>: <a href=\"https:\/\/www.surveyophthalmol.com\/article\/S0039-6257(17)30251-5\/fulltext\">Survey of Ophthalmology<\/a> \u2013 <strong>Optic Nerve Head Problem.<\/strong>\u00a0 Rohan Verma, MD, Kevin Chen, MD, <a href=\"https:\/\/retinamdoc.com\/provider\/hema-ramkumar-m-d\/\">Hema L. Ramkumar, MD<\/a>, Michael H. Goldbaum, MD, Carol L. Shields, MD.<\/p>\n<p><strong><u>August 2016:<\/u><\/strong> <a href=\"https:\/\/www.asrs.org\/\">American Society of Retina Specialists<\/a> Annual Meeting, San Francisco, CA.\u00a0 Presentation:\u00a0 <strong>Recurrence Rate of choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol<\/strong>.\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean D. Adrean, MD<\/a>, Siyang Chaili, BS, <a href=\"https:\/\/retinamdoc.com\/provider\/scott-grant-m-d\/\">Scott Grant, MD<\/a>, <a href=\"https:\/\/retinamdoc.com\/provider\/ash-pirouz-m-d\/\">Ash Pirouz, MD<\/a>.<\/p>\n<p><strong><u>July 2016:<\/u><\/strong> <a href=\"https:\/\/www.surveyophthalmol.com\/article\/S0039-6257(15)00218-0\/fulltext\">Survey of Ophthalmology, An International Review Journal<\/a> \u2013 <strong>A Baby with a Lot of Nerve<\/strong>.\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/hema-ramkumar-m-d\/\">Hema Ramkumar, MD<\/a>, Rohan Verma, MD, Janet Crow, MD, Shira Robbins, MD, David B. Granet, MD.<\/p>\n<p><strong><u>July 2011<\/u><\/strong>: <a href=\"https:\/\/www.surveyophthalmol.com\/article\/S0039-6257(11)00043-9\/fulltext\">Survey of Ophthalmology, an International Review Journal<\/a> \u2013 <strong>Ophthalmic Manifestations and Histopathology of Xeroderma Pigmentosum:\u00a0 Two Clinicopathological Cases and a Reivew of the Literature.<\/strong>\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/hema-ramkumar-m-d\/\">Hema Ramkumar, MD<\/a>, Brian P. Brooks, MD, PhD, Xiaoguang Cao, MD, Deborah Tamura, RN, MS, John J. DiaGiovanna, MD, Kenneth H. Kraemer, MD, Chi-Chao Chan, MD.<\/p>\n<p><strong><u>December 2006<\/u><\/strong>: <a href=\"https:\/\/www.aaojournal.org\/article\/S0161-6420(06)00886-4\/fulltext\">Journal of Ophthalmology &#8211; American Academy of Ophthalmology<\/a> \u2013 <strong>Trends of Penetrating Keratoplasty in the United States from 1980 to 2004.<\/strong>\u00a0 Jason K. Darlington, MD, <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean Adrean, MD<\/a>, Ivan R Schwab, MD, FACS.<\/p>\n<p><strong><u>December 2003<\/u><\/strong>: <a href=\"https:\/\/www.ajo.com\/article\/S0002-9394(03)00716-5\/fulltext\">American Journal of Ophthalmology<\/a> \u2013 <strong>Central Retinal Vein Occlusion and Renal Cell Carcinoma<\/strong>.\u00a0 <a href=\"https:\/\/retinamdoc.com\/provider\/sean-d-adrean-m-d\/\">Sean Adrean, M.D<\/a>., Ivan R. Schwab, MD, FACS<\/p>\n<p style=\"font-weight: 400;\">\n","protected":false},"excerpt":{"rendered":"<p>link1\u00a0 link2\u00a0 The Orange County Eye Project (OCEP) was started to help the underserved population in Orange County to receive retina care for blinding eye disease such as diabetic retinopathy. OCEP has expanded its services to address the underserved population&#8217;s general ophthalmology needs as well. Dr. Adrean serves on the advisory board for OCEP and&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":66,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"_links":{"self":[{"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/pages\/678"}],"collection":[{"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/comments?post=678"}],"version-history":[{"count":5,"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/pages\/678\/revisions"}],"predecessor-version":[{"id":1332,"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/pages\/678\/revisions\/1332"}],"up":[{"embeddable":true,"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/pages\/66"}],"wp:attachment":[{"href":"https:\/\/retinamdoc.com\/wp-json\/wp\/v2\/media?parent=678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}